Drug Product CDMO Service

Products

Information

Synergizing with US site for global clients, Porton has established end-to-end drug product CDMO platform, integrating global experts and formulation development technologies. The core technology team has experience of over 30 years in big pharma companies and drug product industry. The core R&D, technology and production team has over 10-year hands-on experience in R&D, process development, tech transfer and optimization, life cycle management of innovative and generic drugs. Based on QbD principle, Porton pharmatech provides services from process development, through analytical development and IND filling support for global innovators with solving real issues during development and manufacturing and accelerating from clinics to market.
All categories
Contract Research Organisations (CROs)Services
Main Categories
Contract Research Organisations (CROs)
Porton Pharma SolutionsWith over 5,000 customer-centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecule APIs, dosage forms and biologics. By efficiently advancing development and enabling commercialization of multiple high-impact therapies, Porton is proud to have earned the trust of some of the world's leading and most innovative pharmaceutical companies in the world.

Log in

See all the content and easy-to-use features by logging in or registering!